Correlation Between Cognition Therapeutics and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Cognition Therapeutics and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Navidea Biopharmaceutica.
Diversification Opportunities for Cognition Therapeutics and Navidea Biopharmaceutica
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cognition and Navidea is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Navidea Biopharmaceutica
Given the investment horizon of 90 days Cognition Therapeutics is expected to generate 0.79 times more return on investment than Navidea Biopharmaceutica. However, Cognition Therapeutics is 1.26 times less risky than Navidea Biopharmaceutica. It trades about -0.03 of its potential returns per unit of risk. Navidea Biopharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 264.00 in Cognition Therapeutics on September 2, 2024 and sell it today you would lose (224.00) from holding Cognition Therapeutics or give up 84.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 31.05% |
| Values | Daily Returns |
Cognition Therapeutics vs. Navidea Biopharmaceuticals
Performance |
| Timeline |
| Cognition Therapeutics |
| Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cognition Therapeutics and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Navidea Biopharmaceutica
The main advantage of trading using opposite Cognition Therapeutics and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.| Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
| Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |